share_log

Ademi LLP Investigates Claims of Securities Fraud Against Akero Therapeutics, Inc.

Ademi LLP Investigates Claims of Securities Fraud Against Akero Therapeutics, Inc.

Ademi LLP調查針對Akero Therapeutics, Inc.的證券欺詐指控
PR Newswire ·  04/02 18:05

MILWAUKEE, April 2, 2024 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Akero (Nasdaq: AKRO). The investigation results from inaccurate statements Akero may have made regarding its business operations and prospects.

密爾沃基,2024年4月2日 /PRNewswire/ — Ademi LLP正在調查可能針對Akero(納斯達克股票代碼:AKRO)的證券欺詐指控。調查源於Akero可能就其業務運營和前景發表的不準確陳述。

Click here to learn more about the investigation: or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

點擊此處了解有關調查的更多信息:或撥打古裏·阿德米的免費電話866-264-3995。您無需承擔任何費用或義務。

The investigation focuses on Akero's representations regarding its Phase 2b clinical study evaluating efruxifermin (EFX) in treating patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH). In October 2023, Akero reported that 22% of patients receiving a lower dose of EFX and 24% of patients receiving a higher dose experienced an improvement of at least one stage in liver fibrosis with no worsening of NASH by week 36. However, this improvement wasn't statistically significant compared to the results for placebo.

該調查的重點是Akero對其2b期臨床研究的陳述,該研究評估了依氟西弗明(EFX)治療非酒精性脂肪肝炎(NASH)引起的代償性肝硬化患者。2023年10月,Akero報告稱,在接受較低劑量EFX的患者中,有22%和接受更高劑量的患者中,有24%的肝纖維化在第36周之前改善了至少一個階段,NASH沒有惡化。但是,與安慰劑的結果相比,這種改善在統計學上並不顯著。

If you wish to obtain additional information or have information about this investigation, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995,

如果你想獲得更多信息或了解有關本次調查的信息,請致電 [email protected] 或免費電話:866-264-3995 與 Guri Ademi 聯繫,

We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

我們專門從事證券欺詐和股東訴訟。欲了解更多信息,請隨時致電我們。律師廣告。先前的結果並不能保證類似的結果。

Contact:
Ademi LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001

聯繫人:
Ademi LLP
Guri Ademi
東雷頓大道 3620 號
威斯康星州庫達希 53110
免費電話:(866) 264-3995
傳真:(414) 482-8001

SOURCE Ademi LLP

來源 Ademi LLP

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論